Strong Q1, but inventory buildup masks volume sustainability

Delivered 22.5% YoY growth; volume stated as high-single-digit (~9%), price pass-through real but vague quantification

Delivered OPM 10.0%, EBIT grew 72%, consistent with claimed expansion

Delivered PAT growth 75.3% YoY, EPS claim aligns

Delivered 10.0% OPM this quarter. Management hedged, citing external factors beyond control, no forward target given

Acknowledged but stated hard to quantify reversal risk; forecast clarity deferred to Q3

Prior call cautioned on volume selectivity; Q1 shows high-single-digit volume (vs prior restraint), confirming customer mix has stabilized. Product mix favoring home care category & sustainability now driving volume alongside price.

10% OPM delivered vs 8%+ prior range. Productivity improvements + pricing offsetting raw-material crisis shock. Margin expansion durable within current cost structure.

Prior call: 'confident in margin protection'. This call: no FY27 targets, won't commit to 23% growth recurrence. Management clarified strategy but deferred quantified outlook, citing macro uncertainty & inventory reversal risk.

Prior call: 'enough capacity to grow'. This call: reiterated, but cited productivity improvements as the lever (not capex). Competitive sensitivity cited as reason to withhold exact %.

High-single-digit confirmed; no return to low-margin volume. Customer mix stabilized; now growing with right customers in right categories (home care). Profitable growth strategy still intact.

Depends on contract—some quarterly indexing, some more frequent. Most price impact in Q2; Q1 saw less. Transparent inventory sharing with customers; no commitment to frequency.

Can't predict next quarter; external factors drive outcomes. Committed to profitable growth strategy, but won't commit to specific margin level. Blueloop <30% adoption; product mix evolving.

No inorganic plans disclosed. Focus on organic growth, modernization, capex. Will evaluate inorganic if opportunity arises. Cash deployed in liquid funds earning benchmark+ returns.

Absolute numbers up due to price inflation; DSI/DSO ratios constant. No realization risk; normal working capital cycle. Stocked intentionally to avoid shortages amid volatility.

Won't disclose % due to competitive sensitivity. Productivity improvements freeing capacity for 2+ years. Aspiration: grow with customers in selective categories; avoid volume-for-volume's sake.

Mix of market growth, customer mix change, product mix. Won't expect 23% every quarter. Happy if we grow in line with market (3-5% baseline). Inventory buildup real but hard to quantify reversal.

Not sacrificing margin; blueloop has higher cost but also higher price (customer-dependent). 70% on other products. Confident in investment despite low adoption.

Primarily same set of customers; growing share of wallet and customer intimacy.

Management stated external factors (macro, tariffs, inventory reversal) limit commitment. Aspiration to grow in line with market (3-5% baseline) + customer category mix shifts.

Current 23% export growth seen as sustainable if tariff stability holds; capacity available. Southeast Asia, Africa, Europe, Americas ongoing.

Seasonal demand peak & volume normalization visibility pushed to Q3 earnings call. Management uncertain on buildup reversal quantum.

Achieved 10.0% OPM this quarter via pricing + productivity. Management hedged on sustainability; cites commodity/macro volatility as ongoing headwind. Committed to improvement through efficiency, but quantum unclear.

Quarterly (or more frequent) indexing on select contracts; extraordinary costs (Middle East crisis) managed case-by-case. Strategy: no margin sacrifice to volatility.

3-4 quarters of productivity work; more efficiency layers possible but rate of return will diminish (acknowledged as natural process).

Khopoli solar plant 50% power supply; decarbonization 2030 roadmap on track. Equipment upgrades reducing headcount/cost while freeing capacity.

Capital discipline principle; cash deployed to modernization not M&A. Future capex needs under strategic review, not quantified.

Customers built inventory amid Middle East crisis + price expectations. Management acknowledged but can't quantify magnitude or timing. Sharp reversal in Q2/Q3 could deflate 23% growth narrative; deferred clarity to Q3 call creates near-term uncertainty.

23% revenue growth includes material price pass-through (~1/3 of growth). Pricing power varies by contract type (quarterly indexing vs more dynamic). If RM costs stabilize, pass-through dries up and growth decelerates. Middle East supply shock may ease, reducing urgency for customer acceptance of higher prices.

30% of sales from exports (Southeast Asia, Africa, Europe, Americas). Duty/tariff changes create competitive pressure and margin squeeze. Management cited duty stability as challenge early in call; now 'stabilizing a bit' but remains a risk if geopolitical tensions persist.

<30% blueloop market adoption despite capital investment. Regulatory/customer adoption lagging. If regulations don't tighten or customers remain indifferent, blueloop asset ROI could deteriorate. Management betting on future regulation change, but no timeline/visibility.

10% OPM this quarter; analyst asked if this is peak or can improve. Management deflected, citing external factors beyond control. If raw materials normalize rapidly and pricing power fades, margins could compress from here. No quantified forward target creates uncertainty.